Kazuoki Kondo, M.D.
Tanabe Pharma Corporation
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kazuoki Kondo, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:23 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT02354222 · Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin)Tanabe Pharma Corporation · completed · Type 2 Diabetes Mellitus · study director
- Ph3NCT02327182 · Safety Study of MT-4666 in Subjects With Alzheimer's DiseaseTanabe Pharma Corporation · terminated · Alzheimer's Disease · study director
- Ph1NCT01766167 · Clinical Pharmacology Study of MP-424Tanabe Pharma Corporation · completed · Chronic Hepatitis C · study director
- Ph3NCT01753557 · Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis CTanabe Pharma Corporation · completed · Chronic Hepatitis C (CHC) · study director
- Ph3NCT01753570 · Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC)Tanabe Pharma Corporation · completed · Chronic Hepatitis C(CHC) · study director
- Ph3NCT01413204 · Efficacy and Safety Study of TA-7284 in Patients With Type 2 DiabetesTanabe Pharma Corporation · completed · Type 2 Diabetes Mellitus · study director
- Ph3NCT01387737 · Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes MellitusTanabe Pharma Corporation · completed · Type 2 Diabetes Mellitus · study director
- Ph2NCT01022112 · An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 DiabetesTanabe Pharma Corporation · completed · Type 2 Diabetes Mellitus · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.